I am verifying the answers generated by an automatic system to the following question: how much more time does chemo give to people with renal cancer Suggested answer: Targeted cancer therapies such as sunitinib , temsirolimus , bevacizumab , interferon-alpha, and sorafenib have improved the outlook for RCC. Should I validate this answer?
Select from the following. 1). No. 2). Yes.
1).